Seaport Therapeutics has filed to go public. The buzzy Boston biotech was founded by the same team behind the local success story Karuna Therapeutics, which was bought by Bristol Myers Squibb for $14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results